• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

SID 26681509

CAS No. 958772-66-2

SID 26681509 ( —— )

产品货号. M26442 CAS No. 958772-66-2

SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1191 有现货
10MG ¥1847 有现货
25MG ¥3718 有现货
50MG ¥5565 有现货
100MG ¥7930 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    SID 26681509
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。
  • 产品描述
    SID 26681509 is a selective, reversible and competitive human cathepsin L inhibitor (IC50 of 56 nM).(In Vitro):After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent(IC50 : 1.0 nM). SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM.(In Vivo):survival in murine models of sepsis significantly improved SID 26681509 by and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
  • 体外实验
    After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent, demonstrating an IC50 of 1.0 nM. SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM. SID 26681509 shows no inhibitory activity against the serine protease cathepsin G. SID 26681509 inhibits cathepsin V activity with an IC50 value of 0.5 μM. SID 26681509 (1-30 μM) blocks high-mobility group box 1 (HMGB1)-induced TNF-α production dose dependently without altering cell viability.
  • 体内实验
    SID 26681509 treatment significantly improves survival in murine models of sepsis and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
  • 同义词
    ——
  • 通路
    Proteasome/Ubiquitin
  • 靶点
    Cysteine Protease
  • 受体
    Hormone-sensitive lipase (HSL)
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    958772-66-2
  • 分子量
    539.65
  • 分子式
    C27H33N5O5S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 50 mg/mL (92.65 mM)
  • SMILES
    CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Ebdrup, Soren, et al. PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF. US7037905.
产品手册
关联产品
  • Aureusimine B

    Aureusimine B 是一种钙蛋白酶抑制剂,由金黄色葡萄球菌生物膜产生,可能是金黄色葡萄球菌生物膜感染的潜在生物标志物。

  • Liensinine Perchlora...

    Liensinine 是莲子心的活性成分,具有抗高血压作用。

  • Dazcapistat

    Dazcapistat 是一种有效的钙蛋白酶抑制剂,对于钙蛋白酶 1、钙蛋白酶 2 和钙蛋白酶 9 的 IC50 分别 <3 μM。